ABSTRACT
INTRODUCTION
The product of the proto-oncogene c-myc is a highly conserved nuclear phosphoprotein whose expression is closely linked to cellular proliferation and differentiation. Perturbation of c-myc gene expression can be observed in both experimentally induced and naturally occurring tumors in a variety of species and is believed to be one step in tumorigenesis (reviewed in: 1,2). However, the molecular mechanisms for normal and deregulated c-myc expression have remained largely unknown.
Regulation of c-myc gene expression is extremely complex and has been shown to involve several mechanisms, including changes in transcription initiation and elongation, RNA stability, turnover and translation (3) (4) (5) (6) (7) (8) . At the level of transcription initiation, positive and negative cw-acting elements have been identified within the promoter and its 5' flanking region. They have been shown to confer correct initiation and expression to gene constructs microinjected into Xenopus Oocytes or transiently transfected into cell lines (1,9-11 and references therein). The chromatin structure of the human c-myc locus, as mapped by DNase I hypersensitivity, reflects this complex arrangement of control elements. A common pattern of multiple DNase I hypersensitive sites (HSs) has been identified in the promoter and 5' flanking region of the human c-myc gene in cell lines expressing c-myc (3, 7, (12) (13) (14) (15) (16) (17) (18) and changes in this pattern of hypersensitivity have been correlated with alterations in gene activity (3, 7, 18) .
Despite the large body of information, mainly obtained through measurements of RNA steady-state levels in transfection assays, the molecular requirements for normal c-myc transcription in vivo have remained elusive. In previous studies we observed that the 8 kb HindlU-EcoRl gene fragment, comprising all known regulatory elements and HSs, is poorly expressed after stable transfection into Raji cells (19) or lymphoblastoid cell lines (unpublished results). Identical results have recently been reported by Lavenu el al. (20) , demonstrating that these elements are not sufficient for c-myc transgene expression in mice. Thus, efficient transcription in vivo requires additional cK-acting control elements residing outside the coding and upstream flanking region.
In an attempt to identify these putative regulatory elements we mapped HSs in the human c-myc locus in several tumor cell lines and primary lymphocytes. In functional analyses we identified two enhancer elements in the 3' region of the c-mxc gene.
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MATERIALS AND METHODS

Cell lines and cell culture
The EBV-positive Burkitt's lymphoma cell lines BL67 (21) and Raji (22) carrying t(8;14) translocations have been described. BL2 is an EBV-negative Burkitt's lymphoma cell line with a t(8;22) translocation (23) . HL60 is a promyelocytic (24) , U937 a monocytic (25) , and K562 aerythroleukemiacell line (26) . Jurkat is derived from a T-cell leukemia (27) , Colo320 from a colon carcinoma (28) and HeLa from a cervical carcinoma (29) . All cells were grown in RPMI 1640 medium supplemented with 10% fetal calf serum, penicillin, streptomycin and L-glutamine.
Mononuclear cells (MNC) containing >90% lymphocytes were purified from human tonsils. After homogenization cells were purified by Ficoll-Hypaque density centrifugation as described (14) .
Cosmid library
Preparation of the cosmid library has been described (30) . In brief, genomic DNA of the cell line IARC/BL72 was digested partially with Saw3A, dephosphorylated with calf intestine phosphatase, and size-fractionated in a sucrose gradient. The DNA was then ligated with BamHUSacl and BamHVBstEUdigested arms of the cosmid vector Lorist B (31, 32) . Ligated DNA was packaged in vitro with Gigapack gold (Stratagene). Cosmids were propagated in ED8767 bacterial cells.
Sequence analysis
DNA sequence analysis was performed by the dideoxynucleotide chain-termination method using the Sequenase 2.0 sequencing kit according to the guidelines of the manufacturer (USB, Cleveland, USA). Highly repetitive sequences and DNA stretches forming stable secondary structures were analysed with the TaqTrack system (Promega, USA).
Transfection and luciferase assay
Electroporation of the cells was performed essentially as described by Cann et al. (33) . Briefly, 5 x 10 6 (HeLa) or 1 x 10 7 (Raji) cells in a volume of 250 JJ. 1 cold RPMI 1640 medium were mixed with 20 u.g plasmid DNA. The cells were electroporated using a Bio-Rad Gene Pulser with 230 V/960 ^F (Raji) or 300 V/960 \iF (HeLa). Cells were harvested 48 h after transfection and lysed in 200 (il 100 mM K 2 HPO 4 pH 7.8; 1 mM DTT; 1% Triton X-100. Debris was removed by centrifugation at 14000 xg for 10 min. 20 n.1 of the supernatant was added to 350 \il of ice-cold 25 mM glycyl-glycine pH 7.8, 5 mM ATP, 15 mM MgSO 4 and 100 jxl luciferin (0.3 mg/ml in 0.5 M Tris-HCl pH 7.8). The amount of luciferase in the cell extract was measured as bioluminescence with a Lumat LB9501 (Berthold, Wildbach) according to standard protocol (34) . Each sample was analysed in duplicate. Plasmid pSV40-6-gal was used as an internal standard to normalize for transfection efficiency (35) . The 6-galactosidase activity expressed from this cotransfected plasmid was measured as described by Jain and Magrath (36) .
Preparation of DNase I treated nuclei was performed essentially as described (37) . A manuscript with a detailed protocol on preparation of DNase I treated DNA for pulsed field gel electrophoresis is in preparation. Genomic DNAs (10 ug per sample) were digested with the appropriate restriction enzyme, the DNA fragments separated in agarose gels by electrophoresis and transferred to nylon membranes (Hybond N+, Amersham). For PFGE analysis the protocol described by Smith etal. (38) was followed using the Chef-II system (Biorad). The filters were air dried, UV-crosslinked and hybridized overnight in Church buffer (7% SDS, 0.5 M Na 2 HPO 4 pH 7.2, 1 mM EDTA). All probes were 32 P-labeled by random priming according to Feinberg and Vogelstein (39) . The following probes, shown in Figure 6 , were used: HC is a Hindlll-Clal fragment, located upstream of the c-myc promoters (position 1-1071) according to the published sequence (40) . RD is a PCR fragment, located within intron 1 (position 3264-3810). RC1.3 is a c-myc third exon probe (Clal-EcoRl fragment) first described by Eick and Bomkamm (41) . The probes Sac 1.7 and SB 1.3 were described by Sun et al. (42) .
Nucleotide sequence
The nucleotide sequence of the c-myc 3' region has been sent to the EMBL Data Library, the accession number is Z46773.
RESULTS
Chromatin analysis of the c-myc upstream region
To identify additional regulatory elements in the c-myc locus, we performed DNase I hypersensitive site (HS) analyses of cell lines expressing c-myc. Examination of the c-myc chromatin in mononuclear cells (MNC) and in nine tumor cell lines derived from different lineages would not only allow to detect potential tissue specific differences in DNase I hypersensitivity but also to compare the chromatin structure of tumor cell lines to untransformed cells.
DNA from DNase I treated nuclei of BL2, BL67, Raji, U937, K562, HL60, Jurkat, HeLa, Colo320 and mononuclear cells (MNC) was initially digested with EcoRl and evaluated for location of HSs by Southern blot hybridization using probe RC 1.3. Similar studies of the c-myc chromatin have so far been confined to the coding and immediate upstream region of the gene. They have revealed a set of DNase I hypersensitive sites 5' and internal to the gene, which is apparently common to cells expressing c-myc (1, and references within).
All cell lines in the present study consistently displayed the same pattern of HSs, corresponding in position and intensity to those previously described. From the broad panel of different cell lines examined by us (this study) and others (see above), we conclude that transcriptionally active c-myc genes exhibit this pattern of DNase I HS (Fig. 1) .
As also shown in Figure 1 , cleavage by DNase I created additional, smaller subfragments, corresponding to previously unidentified hypersensitive sites located within exon 2 and intron 2. Following the nomenclature of the HSs in the promoter region of c-myc, we designated the three most prominent sites HS VI, VII and VIII. These new sites were present in all cell lines examined, however, their hypersensitivity, as reflected by the intensity of their signals in comparison to the major HSs 1,112 and Ill 1/2 in the promoter region, was strongest in HL60, Colo320, MNC and U937 cells. A/7II was used as restriction enzyme to analyze chromatin structure of the c-myc promoter region in more detail. The rationale behind digesting DNA samples with Afltt and hybridizing the resulting blots to probe RD was 2-fold. Firstly, it allows visualization of HSs in the promoter region as small subbands which is beneficial for fine mapping of their precise location. Secondly, /A/HI generates a restriction fragment of 15 kb allowing to survey the c-myc upstream region for additional hypersensitive sites. Comparison of the different cell lines did not reveal any major differences in intensity and location of the hypersensitive sites in the c-myc promoter region. Instead, these experiments led to the identification of another, albeit weak, HS located 11 kb upstream of PI in Colo320 and HL60 cells which was barely detectable in cell lines without c-myc amplification (Fig. 2) . Chromatin analysis of the farther upstream region is hampered by the lack of genomic probes. To overcome this problem we performed pulsed field gel electrophoresis (PFGE) of DNase I ). The precise location of this site has been determined by using Nar\ as restriction enzyme. In the map below, the positions of the HSs I-III in the promoter region of c-myc and the locations of the probes HC and RD are given. 'G' marks the germline fragment, 'a' an aberrant restriction fragment that is characteristic for Colo320 (28) . Abbreviations for restriction enzymes are: A (Afltt), N (NarY) and R (EcoRI).
treated and Nar\ restricted DNA of Colo320 and HL60 cells and probed with HC. Besides the one 11 kb upstream of PI, we did not detect any further hypersensitive site within the 50 kb Nar\ restriction fragment upstream of c-myc (data not shown).
Mapping HSs in the 3' region of c-myc
The same nuclease treated DNA samples were used to perform chromatin analysis of the c-myc 3' region. Again, EcoRI was initially used in these experiments, therefore all coordinates are given relative to the proximal EcoRI site which marks the end of the ///ndlll-EcoRI c-myc gene fragment (Fig. 3) . Within the 18 kb spanning EcoRI restriction fragment three strong hypersensitive sites were detected, located 1.5,6.5 and 9 kb downstream of c-myc. Interestingly, these HSs were present in some, but not in other cell lines. In HeLa, Colo320 and K562 cells one strong signal was obtained corresponding to HS 1.5, whereas in MNC only HS 9 was detected (Fig. 3) . All Burkitt's lymphoma cell lines (Raji, Fig. 3 ; BL2 and BL67, data not shown) and HL60 showed a similar pattern of hypersensitive sites with HS 6.5 and HS 9 giving strongest signals and several weaker subbands present in the range between 1 and 4 kb. In contrast, no hypersensitive sites were detected in Jurkat and U937 cells. In order to compare the signal intensity of the hypersensitive sites in the 3' region to those within the c-myc gene, identical DNA samples were digested either with EcoRI or Stu\ and separated in parallel by agarose gel electrophoresis. Hybridization of the resulting filters to probe RC 1.3 leads to the simultaneous detection of HSs upstream and downstream of c-myc (Fig. 4) . These experiments also excluded the possibility of false negative results or differences in signal intensity due to the use of different probes. (Fig. 5) . HS 22 on the other hand was detected in all hemopoetic cell lines but not in HeLa or Colo320 cells. In the course of these experiments we noticed that both cell lines with c-myc amplification, HL60 and Colo320, gave rise to aberrant restriction fragments in the amplified allele when probed with Sac
Cosmid isolation and sequence analysis
To identify and further characterize the biological function of the sequences residing within these hypersensitive sites and their putative role in c-myc regulation it was necessary to clone this region 3' of c-myc. Screening of a cosmid library established from the Burkitt's lymphoma cell line IARC/BL72 with probe RC1.3 led to the isolation of several positive clones. One cosmid, termed K88O, was shown by restriction mapping and Southern blot analysis to contain the whole coding part of the gene together with almost 25 kb of its adjacent 3' region in germline configuration (Fig. 6) . Out of this cosmid we subcloned overlapping fragments into the Blueskriptll-KS vector which were subsequently sequenced.
We decided to perform extensive sequence analysis of the c-myc 3' region for two reasons. First, the biological function of the elements within the identified HSs might become apparent by sequence homology to known functional elements. Second, considering the tissue specific character of most HSs, it seemed possible that in still other cell lineages or differentiation stages again new HSs might be formed within this region and these elements again be identified by sequence homology.
So far, contiguous sequence information of the human c-myc locus was available for the 8 kb Hindlll-EcoRl restriction fragment containing promoter as well as coding part of the gene and for the abutting 3 kb £coRl-//indIII downstream fragment (40, 44) . Using subclones out of Cosmid K88O we established the sequence of the adjacent 20.5 kb (Fig. 6) . Subsequently, intensive computer analysis of the complete, 23.5 kb comprising sequence downstream of the EcoRl site was performed. Although six of the eight identified HSs have been mapped within this region, the computer analysis did not reveal any striking homology to other sequences in the EMBL Data Base. Instead, two clusters of transcription factor consensus sequences were identified 5.6 kb and 20.9 kb downstream of c-myc. However, these clusters do not colocalize with the identified HSs, therefore we do not know if they are purely random without biological significance or correspond to elements which are functional in others than the cell lines examined. 
Functional analysis of the c-myc 3' region
To identify a potential regulatory function of the DNase I hypersensitive sites downstream of c-myc, we performed enhancer trap experiments using the luciferase gene as reporter. In the parental plasmid, termed pRF226, the expression of the reporter gene is driven by the c-myc Kpn\-Pvu\\ promoter region, cloned in front of the promoterless luciferase ORF (Fig. 7) . Transient transfection of this plasmid into Raji or HeLa cells leads to a moderate expression of the reporter gene. Subsequently, different restriction fragments of the c-myc 3' region were inserted 3' of the luciferase gene in pRF226 and reporter gene expression was again determined after transient transfection in Raji or HeLa cells. Fragments comprising the clusters of transcription factor binding sequences did not lead to a considerable increase in reporter gene activity. Therefore the entire sequenced c-myc 3' region was systematically subdivided in overlapping fragments and their effect on reporter gene expression determined. Out of more than 50 different fragments tested, two substantially increased luciferase expression in both cell lines compared to pRF226. Plasmid 29i, which contains a Sac\-Xba\ fragment (Pos. 6407-7040) colocalizing with HS 6.5. enhanced gene expression about 3x (in Raji) to 7x (HeLa) (Fig. 7) . The Sacl-AvrU (Pos. 17846-19181) restriction fragment encompassing HS 18 and 19 in plasmid 281b increased reporter gene activity lOx (HeLa) to 15x (Raji). The enhancer activity of both fragments works in either orientation and is not confined to the c-myc promoters. Both fragments were able to stimulate expression of the luciferase gene driven by a B-globin minimal promoter similarly (45) , regardless of their orientation or location within the plasmid.
DISCUSSION
So far regulatory elements of the c-myc gene were assumed to be exclusively located in the promoter region or immediately upstream thereof. However, these putative regulatory elements are not sufficient for c-myc expression after stable transfection (19) , or in transgenic mice (20) , neither do they confer transcriptional activation by TPA nor repression by glucocorticoids as observed for the endogenous alleles in lymphoblastoid cell lines (unpublished results). These observations led to the hypothesis that additional control elements, located outside this gene fragment, are required for c-myc expression. Preferential cleavage by nucleases at specific sites in a gene domain has proven useful to identify in vivo active control elements (for review see: [46] [47] [48] and in all tumor cell lines examined, irrespectively of lineage. The location and intensity of these sites is basically identical to those described for actively transcribed c-myc alleles. Their presence has been reported to correlate with c-myc expression, and their disappearance coincides with transcriptional initiation decrease (7) . Also hypersensitive sites VI, VII and VIII identified here are tightly linked to transcriptional expression of c-myc. In HL60 cells they concomitantly disappear when c-myc transcription is turned off (unpublished results). The relevance of these new HSs within the coding region is unclear. From our results with stably transfected cell lines and from the c-myc transgene experiments we can only conclude that they are not sufficient for c-myc activation. Interestingly, in the murine c-myc gene an antisense promoter was mapped close to exon 3 (49), matching exactly the position of HS VIII. The high degree of overall homology and the apparent conservation of HSs in the c-myc locus of mouse and man (50) implicate that HS VIII may correspond to a similar antisense promoter in the human gene.
A new protocol, based on PFGE of DNase I treated DNA, was developed to study the chromatin structure further upstream of c-myc where no genomic probes were available. In general, the technical limitations to mapping HSs in large restriction fragments reside in: (i) poor resolution of DNA fragments >25 kb by conventional gel electrophoresis and (ii) decreasing signal intensity with fragment size. Mapping of HSs in amplified sequences by PFGE circumvents these limitations but is impaired by the discontinuity of some amplicons (30, this report) . The c-myc amplicons in HL60 and Colo320 have been shown to extend beyond the Narl restriction site 50 kb upstream of c-myc (30) . Furthermore, no aberrant restriction fragments have been detected within this region, indicating that this part of the c-myc amplification unit is in germline configuration. Taking advantage of this method we confirmed the presence of a weak HS 11 kb 5' of PI but did not detect any other HS within the 50 kb Narl restriction fragment. From these experiments we cannot exclude though, that tissue or developmental specific HSs are formed in other than the two cell lines examined.
The c-myc 3' region displayed a rather complex pattern of constitutive and tissue specific HSs. Of the eight hypersensitive sites identified, three were detected in all cell lines examined, whereas the presence of the other five HSs was dependent on cell lineage. The identical pattern of HSs found within the gene excludes the possibility that these differences are due to varying experimental conditions. These changes in chromatin organization depending on cell line are the first to be described in the c-myc locus.
All three Burkitt's lymphomacell lines tested showed essentially the same chromatin structure irrespective of EB V status or type of chromosomal translocation. In these experiments we could not discriminate between signals derived from the normal or the translocated allele, therefore it remains to be demonstrated whether this chromatin structure is characteristic for B-cells or caused by the juxtaposition of c-myc to the strong enhancer elements in the immunoglobulin loci. However, preliminary data from B-cell lines without chromosomal translocation indicates that this pattern of HSs is B-cell specific and not dependent on immunoglobulin enhancers.
With the exception of HS 25 all non-constitutive HSs were present in several cell lines of different origin, thus a clearly tissue specific character could not be attributed to these sites. Moreover, we noticed differences in chromatin organization comparing transformed and primary cells of the same lineage. In mononuclear cells of tonsils, consisting mostly of T-cells, a strong HS was detected 9 kb 3' of c-myc whereas in the T-cell tumor cell line Jurkat this site was completely absent. The signal intensity of HS 9 in MNC argues against the possibility that it is derived from a subpopulation of cells other than T-lymphocytes. These results indicate that a tissue or developmental specific character of HSs may be lost in tumor cells. Thus, for clearly demonstrating a correlation between hypersensitive sites and a certain cell lineage, chromatin analyses of more cell lines of the same lineage and of untransformed cells will be required.
The biological function of the elements residing within the HSs did not become apparent by obtaining their sequence information. Computer analysis of 23.5 kb c-myc downstream sequence, encompassing 5 HSs, did not reveal any striking homology to other sequences in the EMBL Data Base.
In order to identify regulatory elements, overlapping fragments spanning the entire sequenced c-myc 3' region were tested in Unexpectedly, fragment 29i enhanced transcription of the reporter gene even more in HeLa than in Raji cells although the corresponding endogenous HS 6.5 is completely absent. Similar results have been described for the lysozyme gene (51) . These data suggest that developmental or tissue specificity of regulatory elements can be achieved in at least two ways: (i) by restricted expression of fra/w-factors binding to these elements or (ii) by rendering these cw-elements inaccessible to regulatory factors as a consequence of their nucleosomal packaging. In the latter case tissue specificity is dependent on the expression of factors that enable activating proteins to bind to these elements. If the m-acting DNA sequence is already present in an accessible form as in the case of transient transfection, this mechanism of cell type specific regulation is abolished. This model is supported by recent findings demonstrating that the ability of transcripional activators to bind nucleosomal DNA is a property of only a subset of DNA-binding factors. For instance, the glucocorticoid receptor binds to a positioned nucleosome reconstituted over the mouse mammary tumor virus promoter, whereas nuclear factor I does not bind its site located at the end of the same nucleosome unless the glucocorticoid receptor has disrupted the nucleosomal core (reviewed in 52). According to this scenario, ternary complexes of histones and DNA-binding factors would be less inhibitory to binding of additional factors. In conclusion, nuclear chromatin is less permissive for transcription factor access and binding in vivo may depend on cooperative interactions between multiple DNA-binding factors.
Interestingly, the region encompassing the second enhancer element is not amplified in HL60 and Colo320 cells. More cell lines with c-myc amplification have to be investigated in order to determine if this is purely accidental or a more common feature of c-myc amplicons. Supporting evidence for an important regulatory function of this region has been presented in two other reports. In rodent T-cell lymphomas, Tsichlis etal. (53) identified a Moloney murine leukemia virus integration site about 20 kb 3' of c-myc. This locus termed MLVI-4 was shown to be conserved between rat, mouse and man and is located within enhancer fragment 281b. Provirus insertion, leading to c-myc deregulation is well documented but poorly understood. This deregulation is assumed to be caused by a transcriptional activation via provirus LTR enhancer or alternatively by the disruption of control element(s) involved in c-myc regulation.
In Southern blot analyses of human multiple myeloma, Palumbo et al. (54) detected genomic rearrangements in 16% of tumors with probe SB 1.3, whereas the c-myc coding part was almost never affected. The same authors also noticed a direct correlation between these rearrangements and poor response to therapy. Taken together, these results implicate, that the disruption of an enhancer element identified within this region either by provirus insertion, genomic rearrangement or non-amplification may be an important event in the tumorigenesis of these cells, possibly by affecting c-myc regulation. The idea, that the disruption of an activating element, possibly involved in the normal expression of a gene, may lead to its transcriptional deregulation seems contradictory and clearly deserves further verification. However, these findings could easily be reconciled in a model where this enhancer element contributes to c-myc expression indirectly for example by regulating the transcription of another gene which in trans affects c-myc expression. In this context it seems noteworthy that we have identified a promoter region close to this enhancer element (unpublished results). Therefore it will not only be necessary to test if these enhancer elements activate c-myc in vivo but also to demonstrate a functional interplay between these elements and c-myc in their genomic context. To address these questions we began to reconstitute the entire sequenced c-myc locus on a episomally replicating plasmid to test this hypothesis after stable transfection in vivo.
